Does reduced cathepsin activity contribute to skin and lung fibrosis in patients with systemic sclerosis and related disorders?

Garton, Mark
Kelly, Clive

Department of Medicine, Royal Shrewsbury Hospital, Shrewsbury, UK
Departments of Rheumatology and Chest Medicine, James Cook University Hospital, Middlesbrough, UK

Correspondence to: Mark Garton, Department of Medicine, Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury, Shropshire SY3 8XQ, UK. E-mail: [email protected]

Accepted October 02, 2023

Revised October 23, 2023

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Rheumatology 63(3):p e81-e82, March 2024. | DOI: 10.1093/rheumatology/kead549